Johannes R Kratz

Summary

Affiliation: University of California
Country: USA

Publications

  1. doi request reprint Genomic prognostic models in early-stage lung cancer
    Johannes R Kratz
    Department of Surgery, University of California San Francisco Cancer Center, CA 94143 0128, USA
    Clin Lung Cancer 10:151-7. 2009
  2. pmc Cancer stem cells in lung tumorigenesis
    Johannes R Kratz
    Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA
    Ann Thorac Surg 89:S2090-5. 2010
  3. doi request reprint Analytical validation of a practical molecular assay prognostic of survival in nonsquamous non-small cell lung cancer
    Johannes R Kratz
    Thoracic Oncology Program, Department of Surgery, University of California, San Francisco, San Francisco, CA, USA
    Diagn Mol Pathol 22:65-9. 2013
  4. pmc The role of stem cells in airway repair: implications for the origins of lung cancer
    Michael S Mulvihill
    Thoracic Oncology Program, Department of Surgery, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94115, USA
    Chin J Cancer 32:71-4. 2013
  5. pmc Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2
    Kush M Parmar
    Center for Excellence in Vascular Biology, Department of Pathology, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
    J Clin Invest 116:49-58. 2006

Collaborators

  • Mark R Segal
  • Michael S Mulvihill
  • Kush M Parmar
  • David M Jablons
  • Biao He
  • Patrick Pham
  • Guohao Dai
  • Zhiyong Lin
  • H Benjamin Larman
  • Sripriya N Moorthy
  • Michael A Gimbrone
  • Guillermo Garcia-Cardena
  • Mukesh K Jain
  • Eric T Wang
  • Yuzhi Zhang

Detail Information

Publications5

  1. doi request reprint Genomic prognostic models in early-stage lung cancer
    Johannes R Kratz
    Department of Surgery, University of California San Francisco Cancer Center, CA 94143 0128, USA
    Clin Lung Cancer 10:151-7. 2009
    ..An effort to develop a robust genomic model for use in the clinical setting should be prompted by encouraging results obtained by the use of a quantitative PCR-based genomic signature in the field of breast oncology...
  2. pmc Cancer stem cells in lung tumorigenesis
    Johannes R Kratz
    Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA
    Ann Thorac Surg 89:S2090-5. 2010
    ..Continued research in the field of lung cancer stem cell biology is vital, as ongoing efforts promise to yield new prognostic and therapeutic targets...
  3. doi request reprint Analytical validation of a practical molecular assay prognostic of survival in nonsquamous non-small cell lung cancer
    Johannes R Kratz
    Thoracic Oncology Program, Department of Surgery, University of California, San Francisco, San Francisco, CA, USA
    Diagn Mol Pathol 22:65-9. 2013
    ....
  4. pmc The role of stem cells in airway repair: implications for the origins of lung cancer
    Michael S Mulvihill
    Thoracic Oncology Program, Department of Surgery, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94115, USA
    Chin J Cancer 32:71-4. 2013
    ..The implications of a stem cell origin of lung cancer are reviewed, and the importance of ongoing research to identify novel therapeutic and prognostic targets is reiterated...
  5. pmc Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2
    Kush M Parmar
    Center for Excellence in Vascular Biology, Department of Pathology, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
    J Clin Invest 116:49-58. 2006
    ..KLF2 therefore serves as a mechano-activated transcription factor important in the integration of multiple endothelial functions associated with regions of the arterial vasculature that are relatively resistant to atherogenesis...